Methods and compositions for inducing mitochondrial biogenesis are provided. In some aspects, methods for the treatment of diseases such as acute kidney disease (AKI) or a muscle wasting disease by administering tomoxetine, nisoxetine, fenoterol, formoterol, or procaterol to an individual are provided.

Discloses is a passive transdermal delivery device comprising: a backing substrate

THE PRESENT INVENTION PROVIDES A DRY SYRUP PREPARATION OF PROCATEROL HAVING EXCELLENT STABILITY WHICH COMPRISES AT LEAST ONE ACTIVE INGREDIENT SELECTED FROM PROCATEROL OR A SALT THEREOF AN ASOCRBIC ACID AND A SPECIFIC AMOUNT OF CITRIC ACID. THE PREPARATION OF THE PRESENT INVENTION IS VERY STABLE AND THE ACTIVE PROCATEROL OR A SALT THEREOF CAN BE KEPT WITHOUT BEING DECOMPOSED EVEN BY DILUTING WITH A TAP WATER OWING TO ASCORBIC ACIDSAND FURTHER HAS EXCELLENT STORAGE STABILITY WITHOUT DECOMPOSITION...

PROBLEM TO BE SOLVED: To provide a procaterol dry syrup preparation hardly causing degradation of the procaterol or a salt thereof of an active ingredient contained in the preparation even if the preparation is diluted with tap water.SOLUTION: The procaterol dry syrup preparation contains at least one kind selected from the group consisting of the procaterol and the salt thereof ascorbic acids and a specific amount of citric acid. The ascorbic acids inhibit the degradation of the procaterol or t...

The present invention provides a dry syrup preparation of procaterol having excellent stability which comprises at least one active ingredient selected from procaterol or a salt thereof an ascorbic acid and a specific amount of citric acid. The preparation of the present invention is very stable and the active procaterol or a salt thereof can be kept without being decomposed even by diluting with a tap water owing to ascorbic acids and further has excellent storage stability without decompositio...